RBB

Dr. Dana's Nail Renewal System Relaunches Under Rare Beauty Brands

Retrieved on: 
Thursday, May 19, 2022
Multimedia, Amazon (company), RBB, Mastic, Nail, Paraben, Skin, Acquisition, Diagnosis, Formaldehyde, Cosmetics

BOSTON, May 19, 2022 /PRNewswire/ -- Rare Beauty Brands (RBB) today announced the relaunch of Dr. Dana's famous Nail Renewal System, developed by world-renowned dermatologist and nail expert Dr. Dana Stern. The Nail Renewal System, which retails for $30, is available now on drdananails.com and will soon be available on Amazon.com.

Key Points: 
  • BOSTON, May 19, 2022 /PRNewswire/ -- Rare Beauty Brands (RBB) today announced the relaunch of Dr. Dana 's famous Nail Renewal System, developed by world-renowned dermatologist and nail expert Dr. Dana Stern.
  • The Nail Renewal System, which retails for $30, is available now on drdananails.com and will soon be available on Amazon.com .
  • "Through the Nail Renewal System process, we are removing damaged superficial nail cells just like you do when you exfoliate the skin, and we're hydrating and treating."
  • Rare Beauty Brands (RBB) is a global brand platform that incubates, acquires, and accelerates purpose-driven beauty brands.

F/m Investments to Enter the ETF Market; Partners with RBB Fund, Inc.

Retrieved on: 
Tuesday, May 17, 2022
Consulting, Professional Services, Finance, Investment, CEO, Solution, RBB, Industry, F&M Bank (Timberville, Virginia), ETF, Growth, Marketing, Company, Mutual fund, Financial adviser

We are excited to be entering the ETF space, said David Littleton, CEO of F/m.

Key Points: 
  • We are excited to be entering the ETF space, said David Littleton, CEO of F/m.
  • We created North Slope specifically to assist boutiques in accessing the ETF market.
  • We are excited to be working with F/m as they expand their offerings into ETFs, said Arnold Reichman, Chairman of RBB.
  • RBB oversees approximately $19 billion in assets, supporting 11 separate investment advisors, over 20 unaffiliated subadvisors, and over 40 mutual fund or ETF offerings.

Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Corcept, and RBB and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, May 17, 2022
Accountability Act, Company, U.S. Department of Justice Office of Legislative Affairs, U.S. Securities and Exchange Commission, Royal Business Bank, Medal, News, Alpha, NASDAQ, DOJ, Corcept Therapeutics, RBB, Privacy Office of the U.S. Department of Homeland Security, Health Insurance Portability and Accountability Act, District, EVP, Sale, CORT, CDNA, HIPAA, HuffPost, SEC, Record, CEO, GLOBE, Online gambling, Security (finance), Audit, Animal, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • The DOJ is investigating business practices related to CareDxs kidney testing and phlebotomy services.
  • On this news, Medallions stock fell up to 27% during intraday trading on December 29, 2021, thereby injuring investors.
  • For more information on the RBB Bancorp investigation go to: https://bespc.com/cases/RBB
    About Bragar Eagel & Squire, P.C.

RBB Bancorp Files Supplement to Proxy Statement

Retrieved on: 
Monday, May 16, 2022
Banking, Professional Services, Finance, Company, Dodd–Frank Wall Street Reform and Consumer Protection Act, Bank Secrecy Act, Private Securities Litigation Reform Act, Annual general meeting, U.S. Securities and Exchange Commission, Terrorism, Risk management, Royal Business Bank, Supplement, London Interbank Bid Rate, Public Company Accounting Oversight Board, Bank, NASDAQ, Coronavirus, Failure, Investor Protection and Securities Reform Act of 2010, Exchange, COVID-19, RBB, Proxy, Weather, Financial Accounting Standards Board, Lists of disasters, Consumer Protection Act, Current Expected Credit Losses, Compliance, Forward-looking statement, Technology, Update, SBA, Adoption, Proxy statement, Security (finance), SEC, Director, RAM, Acquisition, Annual report, Audit

RBB Bancorp (NASDAQ: RBB ) and its subsidiaries, Royal Business Bank ("the Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as "the Company", announced that the Company has filed with the Securities and Exchange Commission a Supplement to the Companys Proxy Statement that was distributed on or about April 18, 2022 that provides updated information with respect to the Annual Meeting of Shareholders (the Annual Meeting) of RBB Bancorp (the Company) to be held on Wednesday, May 18, 2022.

Key Points: 
  • RBB Bancorp (NASDAQ: RBB ) and its subsidiaries, Royal Business Bank ("the Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as "the Company", announced that the Company has filed with the Securities and Exchange Commission a Supplement to the Companys Proxy Statement that was distributed on or about April 18, 2022 that provides updated information with respect to the Annual Meeting of Shareholders (the Annual Meeting) of RBB Bancorp (the Company) to be held on Wednesday, May 18, 2022.
  • RBB Bancorp is a community-based financial holding company headquartered in Los Angeles, California.
  • As of March 31, 2022, the company had total assets of $4.0 billion.
  • There can be no assurance that other factors not currently anticipated by RBB will not materially and adversely affect its business, financial condition and results of operations.

Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Corcept, and RBB and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, May 12, 2022
Accountability Act, Company, U.S. Department of Justice Office of Legislative Affairs, U.S. Securities and Exchange Commission, Royal Business Bank, Medal, News, Alpha, NASDAQ, DOJ, Corcept Therapeutics, RBB, Privacy Office of the U.S. Department of Homeland Security, Health Insurance Portability and Accountability Act, District, EVP, Sale, CORT, CDNA, HIPAA, HuffPost, SEC, Record, CEO, GLOBE, Online gambling, Security (finance), Audit, Animal, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • The DOJ is investigating business practices related to CareDxs kidney testing and phlebotomy services.
  • On this news, Medallions stock fell up to 27% during intraday trading on December 29, 2021, thereby injuring investors.
  • For more information on the RBB Bancorp investigation go to: https://bespc.com/cases/RBB
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Is Investigating Corcept, RBB, and Verra and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, May 7, 2022
Mission statement, Corcept Therapeutics, Record, U.S. Securities and Exchange Commission, NASDAQ, GLOBE, Company, EVP, Royal Business Bank, HIPAA, CORT, District, Form 10-K, RBB, Sale, Accountability Act, Health Insurance Portability and Accountability Act, SEC, CEO, News, Therapy, Online gambling, Audit, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Verra Mobilitys stock dropped as much as 7.6% during intraday trading on February 28, 2022, thereby injuring investors.
  • For more information on the Verra investigation go to: https://bespc.com/cases/VRRM
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

RBB Bancorp Renews Buyback

Retrieved on: 
Monday, May 2, 2022
Banking, Professional Services, Finance, Board, COVID-19, Weather, RAM, Board of directors, U.S. Securities and Exchange Commission, SBA, Dodd–Frank Wall Street Reform and Consumer Protection Act, Financial Accounting Standards Board, Forward-looking statement, Private Securities Litigation Reform Act, Risk management, NASDAQ, Consumer Protection Act, Company, Current Expected Credit Losses, Failure, Royal Business Bank, London Interbank Bid Rate, Security (finance), Update, Public Company Accounting Oversight Board, Coronavirus, Terrorism, Annual report, Compliance, Asset-backed security, RBB, Lists of disasters, Adoption, Bank, Bank Secrecy Act, SEC, Technology, Acquisition

RBB Bancorp (NASDAQ: RBB ) and its subsidiaries, Royal Business Bank ("the Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as "the Company", announced that its Board of Directors has adopted a stock repurchase program.

Key Points: 
  • RBB Bancorp (NASDAQ: RBB ) and its subsidiaries, Royal Business Bank ("the Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as "the Company", announced that its Board of Directors has adopted a stock repurchase program.
  • Under the repurchase program, the Company may repurchase up to 500,000 shares of its common stock, or approximately 2.59% of its outstanding shares.
  • RBB Bancorp is a community-based financial holding company headquartered in Los Angeles, California.
  • There can be no assurance that other factors not currently anticipated by RBB will not materially and adversely affect its business, financial condition and results of operations.

Bragar Eagel & Squire, P.C. Is Investigating RBB, Verra, Mullen, and Arqit and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, May 2, 2022
Hindenburg, Nikola Corporation, CEO, Royal Business Bank, The Wall Street Journal, GLOBE, Others, Wall Street, Technology, Company, Mission statement, Acquisition, News, Mullen, Hindenburg Research, NASDAQ, EV, EVP, Industry, SEC, SPAC, Form 10-K, RBB, Online gambling, Audit, Cryptocurrency, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, RBB Bancorps stock price declined by $2.69 per share, or approximately 10.45%, from $25.75 to $23.06 over two trading days.
  • On this news, Verra Mobilitys stock dropped as much as 7.6% during intraday trading on February 28, 2022, thereby injuring investors.
  • For more information on the Arqit investigation go to: https://bespc.com/cases/ARQQ
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, Corcept, RBB, and Verra and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, April 26, 2022
Royal Business Bank, News, Health Insurance Portability and Accountability Act, Letter, CEO, Investigational New Drug, U.S. Securities and Exchange Commission, IND, Accountability Act, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NASDAQ, Food, District, GLOBE, Sale, Patient, Form 10-K, EVP, HIPAA, Mission statement, Corcept Therapeutics, Company, CORT, SEC, RBB, FDA, Record, Online gambling, Pharmaceutical industry, Audit, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Cortexymes stock price fell $44.17 per share, or 76.58%, to close at $13.51 per share on October 27, 2021.
  • On this news, Verra Mobilitys stock dropped as much as 7.6% during intraday trading on February 28, 2022, thereby injuring investors.
  • For more information on the Verra investigation go to: https://bespc.com/cases/VRRM
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Is Investigating RBB, Verra, Natera, and Li-Cycle and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, April 21, 2022
Royal Business Bank, News, CEO, Report, Enron, Miscarriage, NASDAQ, GLOBE, NTRA, The New York Times, Patient, Form 10-K, EVP, Mission statement, Company, SEC, RBB, PAETEC Holding Corp., NYSE, Abuse, Time, Online gambling, Audit, Textile, Natera, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, RBB Bancorps stock price declined by $2.69 per share, or approximately 10.45%, from $25.75 to $23.06 over two trading days.
  • On this news, Nateras stock declined as much as 3.5% during intraday trading on January 3, 2022, thereby injuring investors.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.